← Eichor
Study identifier: NCT03150693 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

Condition: B Acute Lymphoblastic Leukemia  ·  Sponsor: Alliance for Clinical Trials in Oncology

PhasePhase 3
Planned participants303
Who can joinAll sexes, 18 Years to 39 Years
Healthy volunteersNo

About this study

This phase III trial studies the side effects of inotuzumab ozogamicin and how well it works when given with frontline chemotherapy in treating patients with newly diagnosed B acute lymphoblastic leukemia. Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a chemotherapy drug called ozogamicin. Inotuzumab is a form of targeted therapy because it attaches to specific molecules (receptors) on the surface of cancer cells, known as CD22 receptors, and delivers ozogamicin to kill them. Chemotherapy drugs, such as \[intervention\], work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving inotuzumab ozogamicin with chemotherapy may work better in treating young adults with B acute lymphoblastic leukemia.

This description comes directly from the study's public registry record.

Talk to the study team

Daniel J. DeAngelo, MD, PhD  ·  617-632-2645  ·  daniel_deangelo@dfci.harvard.edu

Always discuss trial participation with your own doctor first.

Locations (460)

University of Alabama at Birmingham Cancer CenterBirmingham, Alabama, United StatesActive Not Recruiting
Anchorage Associates in Radiation MedicineAnchorage, Alaska, United StatesSuspended
Anchorage Radiation Therapy CenterAnchorage, Alaska, United StatesSuspended
Alaska Breast Care and Surgery LLCAnchorage, Alaska, United StatesSuspended
Alaska Oncology and Hematology LLCAnchorage, Alaska, United StatesSuspended
Alaska Women's Cancer CareAnchorage, Alaska, United StatesSuspended
Anchorage Oncology CentreAnchorage, Alaska, United StatesSuspended
Katmai Oncology GroupAnchorage, Alaska, United StatesSuspended
Providence Alaska Medical CenterAnchorage, Alaska, United StatesSuspended
Fairbanks Memorial HospitalFairbanks, Alaska, United StatesSuspended
Kingman Regional Medical CenterKingman, Arizona, United StatesSuspended
Mayo Clinic Hospital in ArizonaPhoenix, Arizona, United StatesSuspended

+ 448 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03150693